OQROStart free trial
Politician trade (House)

Johnson & Johnson (JNJ): Rep. Kevin Hern (OK01) disclosed a purchase $1K–$15K

Rep. Kevin Hern (OK01) disclosed a purchase of Johnson & Johnson in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
39 days
Disclosure lag
Traded
Dec 5, 2023
Disclosed
Jan 13, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Sep 7, 2023CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  2. Sep 8, 2023CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  3. Sep 11, 2023CongressDisclosed partial sale of JNJ — reported range $15,001 - $50,000
  4. Sep 21, 2023CongressDisclosed sale of JNJ — reported range $100,001 - $250,000
  5. Sep 26, 2023CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  6. Oct 16, 2023CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  7. Oct 24, 2023CongressDisclosed sale of JNJ — reported range $1,001 - $15,000
  8. Dec 5, 2023 · this disclosureCongressDisclosed purchase of JNJ — reported range $1,001 - $15,000

What came next

  1. Dec 5, 2023CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  2. Dec 14, 2023Congress · 1 personMembers of Congress: 2 sales
  3. Jan 19, 2024Congress · 1 personMembers of Congress: 2 sales
  4. Jan 23, 2024CongressDisclosed purchase of JNJ — reported range $1,001 - $15,000
  5. Feb 16, 2024FDARecall: CARTO VIZIGO Bi-Directional Guiding Sheath, REF D128502 The CARTO VIZIGOTM Bi-Directional Guiding Sheath is designed to provide accessibility and maneuverabili…
  6. Feb 20, 2024FDAFDA drug approval: Tecvayli
  7. Feb 26, 2024FDAFDA device clearance: FMS VUE™ Fluid Management and Tissue Debridement System
  8. Mar 1, 2024FDAFDA drug approval: Rybrevant
  9. Mar 8, 2024FDARecall: STRATAFIX Spiral MONOCRYL Plus Bidirectional Knotless Tissue Control Device: STRATAFIX SPIRAL MONOCRYL PLUS BI UD 12+12IN(30+30CM) USP3-0(M2) D/A PS PRM- Indic…
  10. Mar 12, 2024FDARecall: ATTUNE AFFIXIUM Cementless Fixed Bearing Knee with 3DP Technology, Size 6. Component of the ATTUNE Total Knee Replacement System.
  11. Mar 14, 2024FDARecall: Johnson & Johnson VISION Reusable LAMINAR High Flow Irrigation Sleeve and Test Chamber 21 Gauge REF OPOHF21L The irrigation sleeve is a device intended to dire…
  12. Mar 15, 2024FDAFDA drug approval: Edurant
  13. Mar 15, 2024FDAFDA drug approval: Edurant
  14. Mar 15, 2024FDAFDA drug approval: Edurant Ped
  15. Mar 15, 2024FDAFDA device clearance: MILAGRO Interference Screw; MILAGRO ADVANCE Interference Screw
  16. Mar 21, 2024FDAFDA device clearance: DePuy Synthes VOLT Mini Fragment Plating System, DePuy Synthes VOLT Small Fragment Plating System
  17. Mar 21, 2024FDAFDA device clearance: ATTUNE Total Knee System, ATTUNE Cementless Knee System, LPS Limb Preservation System, Sigma High Performance (HP) Partial Knee System
  18. Mar 22, 2024FDAFDA drug approval: Opsynvi
  19. Mar 22, 2024FDAFDA device clearance: Shockwave Intravascular Lithotripsy (IVL) System with the Shockwave E8 Peripheral IVL Catheter
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Johnson & Johnson

For Johnson & Johnson, OQRO holds 14 insider filings (SEC Form 4 or Form 144), 4 Congress trade reports, 119 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JNJ page.

Other recent filings by Rep. Kevin Hern (OK01)

The full history of Rep. Kevin Hern (OK01) is on the profile page.

How this filing works

Explore the data

Other disclosures at Johnson & Johnson

Everything OQRO holds on this company is on its JNJ page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Start free trialAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data